As of September 09, 2026, Grace Therapeutics's top three insider holders are Management Inc. Opaleye (TenPercentOwner, 2.76Mn shares), Vimal Kavuru (Director, 1.19Mn shares), Vimal Kavuru (Director, 1.19Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Management Inc. Opaleye | TenPercentOwner | 0 | 2,760,000 | 2,760,000 | 69.9% | 18 Aug, 2026 |
| 2 | Vimal Kavuru | Director, TenPercentOwner | 0 | 1,188,076 | 1,188,076 | 30.1% | 27 Sep, 2023 |
| 3 | Donald Olds | Director | 381 | 0 | 381 | 0.0% | 05 Sep, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 28 Aug, 2026 | Amresh Kumar | Vp Program Management | Acquired A | 35,760 | $0.00 | $0 | 35,760 | Direct |
| 28 Aug, 2026 | Robert J Delaversano | Principal Financial Officer | Acquired A | 33,660 | $0.00 | $0 | 33,660 | Direct |
| 28 Aug, 2026 | R. Loch Macdonald | Chief Medical Officer | Acquired A | 54,690 | $0.00 | $0 | 54,690 | Direct |
| 28 Aug, 2026 | Prashant Kohli | Chief Executive Officer | Acquired A | 267,160 | $0.00 | $0 | 267,160 | Direct |
| 14 Aug, 2026 | Management Inc. Opaleye | TenPercentOwner | Acquired P | 11,608 | $2.09 | $24.21K | 2,760,000 | Indirect |
| 08 Jan, 2026 | George Kottayil | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Vimal Kavuru | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Edward Neugeboren | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Vimal Kavuru | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Edward Neugeboren | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Edward Neugeboren | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Edward Neugeboren | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | George Kottayil | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | George Kottayil | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Edward Neugeboren | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Vimal Kavuru | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | George Kottayil | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Vimal Kavuru | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | George Kottayil | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Jan, 2026 | Vimal Kavuru | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |